Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2019

View Archived Issues

Fibroblasts specialize, too

Cracking influenza's egg code

CCR5 mutation leads to increased mortality

ECI-006 vaccine demonstrates promising safety and immunogenicity in patients with melanoma

First-in-human results presented for FPA-150 in patients with advanced solid tumors

MYLK genetic variant is associated with risk of pulmonary hypertension in sickle cell disease

Dosing initiated in phase I study of XmAb-22841 bispecific antibody

First patient dosed in phase III PEACE study of pegzilarginase in arginase 1 deficiency

BioInvent seeks IND clearance for phase I/IIa study of anti-FcgammaRllB antibody

Chinese researchers patent PI3K inhibitors

WntRx Pharmaceuticals identifies Wnt signaling inhibitors

Conditional European marketing authorization for Zynteglo for transfusion-dependent beta-thalassemia

Kissei Pharmaceutical describes CGRP receptor antagonists

Polish researchers identify 5-HT6 receptor antagonists

Jeil Pharmaceutical divulges new H+/K+-ATPase inhibitors

Kyowa Hakko Kirin initiates Japanese phase III trial of brodalumab in systemic sclerosis

Oligomerix continues NIH-funded work on tau oligomer inhibitor

First clinical data for Daiichi's IDH inhibitor DS-1001 presented for recurrent glioma

Phase III BLOCKSTONE study of Xofluza to prevent influenza infection meets primary endpoint

Qurient reports phase IIa data on telacebec for TB

FDA clears Nouscom's IND for phase I trial of NOUS-209 in MSI solid tumors

CEPI provides funding to support Themis' development of chikungunya vaccine MK-CHIK

Phase II trial of MD-7246 for IBS-D abdominal pain begins dosing

FDA approves Zerbaxa for hospital-acquired and ventilator-associated bacterial pneumonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...